Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Terminated × Metastatic Castration-resistant Prostate Cancer × radium Ra 223 dichloride × Clear all

Phase

Status

Terminated 2 Completed 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Metastatic Castration-resistant Prostate Cancer 2 Prostatic Neoplasms 1 Multiple Myeloma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

radium Ra 223 dichloride 2 enzalutamide 2 darolutamide 1 avelumab 1 abiraterone 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05301062 2023-09-22

CREDIT

Bayer

Metastatic Castration-resistant Prostate Cancer

NCT04237584 2022-10-07

ESCALATE

MANA RBM

Phase 3 Terminated

23 enrolled 11 charts

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡